NO20042053L - Kloestillende middel - Google Patents
Kloestillende middelInfo
- Publication number
- NO20042053L NO20042053L NO20042053A NO20042053A NO20042053L NO 20042053 L NO20042053 L NO 20042053L NO 20042053 A NO20042053 A NO 20042053A NO 20042053 A NO20042053 A NO 20042053A NO 20042053 L NO20042053 L NO 20042053L
- Authority
- NO
- Norway
- Prior art keywords
- detergent
- evoked
- administering
- prostaglandin derivative
- treating atopy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002234011 | 2002-08-09 | ||
PCT/JP2003/010051 WO2004014394A1 (ja) | 2002-08-09 | 2003-08-07 | 止痒剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20042053L true NO20042053L (no) | 2004-05-18 |
Family
ID=31711882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20042053A NO20042053L (no) | 2002-08-09 | 2004-05-18 | Kloestillende middel |
Country Status (18)
Country | Link |
---|---|
US (1) | US7718701B2 (no) |
EP (1) | EP1527781B1 (no) |
JP (1) | JP3678366B2 (no) |
KR (1) | KR100904583B1 (no) |
CN (1) | CN100408039C (no) |
AT (1) | ATE401895T1 (no) |
AU (1) | AU2003254850B2 (no) |
CA (1) | CA2465103C (no) |
DE (1) | DE60322395D1 (no) |
DK (1) | DK1527781T3 (no) |
ES (1) | ES2309380T3 (no) |
HK (1) | HK1076391A1 (no) |
MX (1) | MXPA04004371A (no) |
NO (1) | NO20042053L (no) |
PL (1) | PL373819A1 (no) |
PT (1) | PT1527781E (no) |
TW (1) | TW200404053A (no) |
WO (1) | WO2004014394A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040266880A1 (en) * | 2002-02-22 | 2004-12-30 | Fumie Sato | Antipruritics |
CN1283624C (zh) | 2002-07-12 | 2006-11-08 | 大正制药株式会社 | 前列腺素衍生物 |
US7737182B2 (en) * | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
ATE401895T1 (de) | 2002-08-09 | 2008-08-15 | Taisho Pharmaceutical Co Ltd | Antipruritisches mittel |
CA2597537A1 (en) | 2005-02-14 | 2006-08-17 | Akihiko Kamiya | Ointment |
CA2624141C (en) * | 2005-10-03 | 2014-07-08 | Nippon Shinyaku Co., Ltd. | Quinazoline derivative and pharmaceutical |
US20100016427A1 (en) * | 2006-08-11 | 2010-01-21 | Taishio Pharmaceutical Co., Ltd. | External preparation comprising prostaglandin derivative |
EP2172202A4 (en) | 2007-06-29 | 2010-06-30 | Taisho Pharmaceutical Co Ltd | AQUEOUS LIQUID AGENT CONTAINING A PROSTAGLANDINE DERIVATIVE |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3126924A1 (de) | 1981-07-03 | 1983-01-20 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel |
US4983629A (en) * | 1983-07-08 | 1991-01-08 | Schering Aktiengesellschaft | 11-haloprostane derivatives, processes for their preparation and their use as medicinal agents |
DE3325175A1 (de) * | 1983-07-08 | 1985-01-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3347128A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
JP2716986B2 (ja) * | 1987-07-17 | 1998-02-18 | シエーリング アクチエンゲゼルシヤフト | 9‐ハロゲン‐(z)‐プロスタグランジン誘導体、その製法及び薬剤としてのその使用 |
US5891910A (en) * | 1987-07-17 | 1999-04-06 | Schering Aktiengesellschaft | 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents |
US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
US5252602A (en) | 1991-10-11 | 1993-10-12 | Rafeul Alam | Effects of misoprostol on allergic responses |
US5403867A (en) * | 1992-02-07 | 1995-04-04 | Kaken Pharmaceutical Co., Ltd. | Preparation for treating wounds or hemorrhoids |
KR100266834B1 (ko) * | 1992-07-24 | 2000-09-15 | 우에하라 아끼라 | 프로스타글란딘 유도체 |
EP0666256A1 (en) * | 1992-10-20 | 1995-08-09 | Taisho Pharmaceutical Co. Ltd | Prostaglandine derivative |
US6124344A (en) * | 1993-12-28 | 2000-09-26 | Allergan Sales, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
JP3579448B2 (ja) | 1993-12-29 | 2004-10-20 | 大正製薬株式会社 | プロスタグランジン誘導体、その塩およびその使用 |
JP3573482B2 (ja) * | 1994-03-07 | 2004-10-06 | 大正製薬株式会社 | プロスタグランジン誘導体およびその使用 |
JP3506485B2 (ja) * | 1994-04-19 | 2004-03-15 | 大正製薬株式会社 | プロスタグランジン誘導体 |
US5807892A (en) * | 1994-09-30 | 1998-09-15 | Alcon Laboratories, Inc. | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
WO1996016935A1 (fr) * | 1994-11-30 | 1996-06-06 | Taisho Pharmaceutical Co., Ltd. | Derive de prostaglandines |
JPH0971539A (ja) | 1995-09-08 | 1997-03-18 | Mochida Pharmaceut Co Ltd | 外用鎮痒剤 |
JPH09169638A (ja) | 1995-10-18 | 1997-06-30 | Sekisui Chem Co Ltd | 皮膚疾患治療用外用剤 |
US5599838A (en) * | 1996-02-23 | 1997-02-04 | Taisho Pharmaceutical Co., Ltd. | Prostaglandin derivatives |
JPH09286775A (ja) * | 1996-04-24 | 1997-11-04 | Taisho Pharmaceut Co Ltd | プロスタグランジン誘導体 |
WO1997045114A1 (en) | 1996-05-30 | 1997-12-04 | Lysis Corporation | The treatment of vascular disease with prostaglandins via a sustained-release dermal patch |
CA2275663C (en) * | 1996-12-23 | 2008-03-18 | Robin Kenneth Stewart Phillips | Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence |
NO317155B1 (no) | 1997-02-04 | 2004-08-30 | Ono Pharmaceutical Co | <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater |
JPH10316564A (ja) | 1997-05-21 | 1998-12-02 | Sekisui Chem Co Ltd | 鎮痒鎮痛外用剤 |
JPH1180031A (ja) | 1997-07-14 | 1999-03-23 | Sekisui Chem Co Ltd | 外用剤及び経皮又は経粘膜吸収性を増進する方法 |
JPH11199478A (ja) * | 1998-01-05 | 1999-07-27 | Hiroshi Nagoshi | レチノイド並びにプロスタグランジンd▲2▼誘導体の抗炎症薬としての使用 |
DE69929594T2 (de) * | 1998-05-25 | 2006-12-07 | Taisho Pharmaceutical Co., Ltd. | Schlafmittel enhaltend prostaglandinderivate |
US6506789B2 (en) * | 1998-06-03 | 2003-01-14 | Shionogi & Co., Ltd. | Methods for the treatment of itching comprising administering PGD2 receptor antagonist |
ATE295183T1 (de) | 1998-06-03 | 2005-05-15 | Shionogi & Co | Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten |
TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
DK1133571T3 (da) | 1998-11-23 | 2006-10-23 | Proteome Sciences Inc | Fremgangsmåder og sammensætning til smertebehandling |
US6191154B1 (en) | 1998-11-27 | 2001-02-20 | Case Western Reserve University | Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
JP2000273083A (ja) * | 1999-03-19 | 2000-10-03 | Taisho Pharmaceut Co Ltd | プロスタグランジン誘導体 |
JP2001089443A (ja) * | 1999-07-19 | 2001-04-03 | Taisho Pharmaceut Co Ltd | プロスタグランジン誘導体 |
WO2001019790A1 (fr) * | 1999-09-10 | 2001-03-22 | Taisho Pharmaceutical Co., Ltd. | Derives de prostaglandine |
ES2213601T3 (es) | 1999-09-14 | 2004-09-01 | MERCK FROSST CANADA & CO. | Acidos carboxilicos y acilsulfonamidas, composiciones que contienen tales compuestos y procedimiento de tratamiento. |
JP2001122786A (ja) * | 1999-10-20 | 2001-05-08 | Taisho Pharmaceut Co Ltd | 睡眠誘発剤 |
JP2001151749A (ja) * | 1999-11-24 | 2001-06-05 | Taisho Pharmaceut Co Ltd | プロスタグランジン誘導体 |
AU778321B2 (en) * | 1999-11-24 | 2004-11-25 | Taisho Pharmaceutical Co., Ltd. | Preparation for nasal administration |
KR20020067594A (ko) * | 2000-01-05 | 2002-08-22 | 오노 야꾸힝 고교 가부시키가이샤 | 5-티아-ω-치환 페닐-프로스타글란딘 E-알콜, 이들의제조 방법 및 이들을 유효 성분으로서 함유하는 약제 |
JP2001220355A (ja) | 2000-02-07 | 2001-08-14 | Teijin Ltd | PPARβ/δ及びγリガンドからなる肥満細胞活性化抑制剤 |
US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
JP4929472B2 (ja) | 2000-08-22 | 2012-05-09 | 小野薬品工業株式会社 | カルボン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤 |
CA2419722A1 (en) | 2000-09-01 | 2003-02-21 | Masaki Asada | Benzoic acid derivatives and drugs containing the same as the active ingredient |
AU2002229611A1 (en) | 2000-12-08 | 2002-06-18 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells |
US20040266880A1 (en) * | 2002-02-22 | 2004-12-30 | Fumie Sato | Antipruritics |
AU2003207102C1 (en) * | 2002-02-22 | 2008-02-21 | Fumie Sato | Antipruritics |
ATE401895T1 (de) | 2002-08-09 | 2008-08-15 | Taisho Pharmaceutical Co Ltd | Antipruritisches mittel |
US7737182B2 (en) * | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
-
2003
- 2003-08-07 AT AT03784565T patent/ATE401895T1/de active
- 2003-08-07 ES ES03784565T patent/ES2309380T3/es not_active Expired - Lifetime
- 2003-08-07 AU AU2003254850A patent/AU2003254850B2/en not_active Ceased
- 2003-08-07 EP EP03784565A patent/EP1527781B1/en not_active Expired - Lifetime
- 2003-08-07 CA CA2465103A patent/CA2465103C/en not_active Expired - Fee Related
- 2003-08-07 PL PL03373819A patent/PL373819A1/xx not_active Application Discontinuation
- 2003-08-07 WO PCT/JP2003/010051 patent/WO2004014394A1/ja active IP Right Grant
- 2003-08-07 DK DK03784565T patent/DK1527781T3/da active
- 2003-08-07 US US10/493,693 patent/US7718701B2/en not_active Expired - Fee Related
- 2003-08-07 PT PT03784565T patent/PT1527781E/pt unknown
- 2003-08-07 CN CNB038017350A patent/CN100408039C/zh not_active Expired - Fee Related
- 2003-08-07 MX MXPA04004371A patent/MXPA04004371A/es active IP Right Grant
- 2003-08-07 DE DE60322395T patent/DE60322395D1/de not_active Expired - Lifetime
- 2003-08-07 KR KR1020047008144A patent/KR100904583B1/ko not_active IP Right Cessation
- 2003-08-07 JP JP2004527356A patent/JP3678366B2/ja not_active Expired - Fee Related
- 2003-08-08 TW TW092121887A patent/TW200404053A/zh not_active IP Right Cessation
-
2004
- 2004-05-18 NO NO20042053A patent/NO20042053L/no not_active Application Discontinuation
-
2005
- 2005-09-27 HK HK05108508.3A patent/HK1076391A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1527781A4 (en) | 2006-12-13 |
AU2003254850B2 (en) | 2008-05-15 |
ES2309380T3 (es) | 2008-12-16 |
JP3678366B2 (ja) | 2005-08-03 |
MXPA04004371A (es) | 2004-08-13 |
EP1527781A1 (en) | 2005-05-04 |
PT1527781E (pt) | 2008-08-12 |
AU2003254850A1 (en) | 2004-02-25 |
CA2465103C (en) | 2011-04-26 |
CN100408039C (zh) | 2008-08-06 |
TW200404053A (en) | 2004-03-16 |
US20050009917A1 (en) | 2005-01-13 |
KR100904583B1 (ko) | 2009-06-25 |
JPWO2004014394A1 (ja) | 2005-12-02 |
WO2004014394A1 (ja) | 2004-02-19 |
CN1620297A (zh) | 2005-05-25 |
ATE401895T1 (de) | 2008-08-15 |
TWI328574B (no) | 2010-08-11 |
CA2465103A1 (en) | 2004-02-19 |
HK1076391A1 (en) | 2006-01-20 |
PL373819A1 (en) | 2005-09-19 |
KR20050026375A (ko) | 2005-03-15 |
DE60322395D1 (de) | 2008-09-04 |
EP1527781B1 (en) | 2008-07-23 |
DK1527781T3 (da) | 2008-11-17 |
US7718701B2 (en) | 2010-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1485360T3 (da) | Natriumkanalblokkere | |
TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
CY1105915T1 (el) | Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar | |
CY1109088T1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης | |
CY1113578T1 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
ATE504315T1 (de) | Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen | |
NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
ATE441418T1 (de) | Verwendung von treprostinil zur verbesserung der nierenfunktion | |
EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
NO20071309L (no) | Fremgangsmate for ekspansjon | |
NO20052884L (no) | Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. | |
EA200600197A1 (ru) | Получение производных соединения 1,3-дифенилпроп-2-ен-1-он | |
BRPI0314814B8 (pt) | anticorpo compreendendo uma variante de fc | |
EA200000358A1 (ru) | Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2 | |
HK1076391A1 (en) | Antipruritic agent | |
NO20074047L (no) | Ny fremgangsmate for fremstilling av substituerte indoler | |
CY1108221T1 (el) | Μεθοδος για την αναπαραγωγη πλευρομουτιλινων | |
EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
EA200401428A1 (ru) | Способ получения цефдинира | |
EA200700807A1 (ru) | Новые циклические и ациклические пропеноны для лечения заболеваний цнс | |
UA87822C2 (ru) | Производные нафтилена как ингибиторы цитохрома p450 | |
ATE443044T1 (de) | Tace inhibitoren | |
EA199900948A1 (ru) | Способ получения 2-арил-3-арил-5-галогенпиридинов, используемых в качестве ингибиторов cox-2 | |
ATE539756T1 (de) | Prostaglandinsubstanzen für die behandlung von fettsucht | |
DK1301475T3 (da) | Arylsulfonamider, som serotoninantagonist til behandling af obesitet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |